NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹995 Cr | ₹752 Cr | ₹465 Cr | ₹308 Cr | ₹248 Cr |
What is the latest Profit & Loss Account Balance ratio of NEULAND LABORATORIES ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹995 Cr |
Mar2024 | ₹752 Cr |
Mar2023 | ₹465 Cr |
Mar2022 | ₹308 Cr |
Mar2021 | ₹248 Cr |
How is Profit & Loss Account Balance of NEULAND LABORATORIES Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹995 Cr | 32.18 | |
Mar2024 | ₹752 Cr | 61.74 | |
Mar2023 | ₹465 Cr | 50.99 | |
Mar2022 | ₹308 Cr | 24.17 | |
Mar2021 | ₹248 Cr | - |
Compare Profit & Loss Account Balance of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹17,010.7 Cr | 3.6% | 8% | 12.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,917.0 Cr | -1.2% | -3.6% | -8.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,982.0 Cr | -6.6% | -12.4% | 22.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,306.0 Cr | 0.7% | 9.1% | 7.2% | Stock Analytics | |
CIPLA | ₹121,442.0 Cr | 0.3% | 1.2% | -5.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,752.0 Cr | 0.4% | -2.8% | -12.7% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 3.6% |
8% |
12.3% |
SENSEX | -0.5% |
-3.1% |
1.4% |
You may also like the below Video Courses